Heart rhythm disorder traces to bacterium lurking in gums: Study
gum disease bacterium P. gingivalis
can slip into the bloodstream and infiltrate the heart. There, it quietly drives scar tissue buildup -- distorting the heart's architecture, disrupting electrical signals, and raising the risk of
atrial fibrillation
(AFib).
Clinicians have long noticed that people with periodontitis, a common form of gum disease, seem more prone to cardiovascular problems.
One recent meta-analysis has linked it to a 30% higher risk of developing AFib, a potentially serious
heart rhythm disorder
that can lead to stroke, heart failure, and other life-threatening complications.
Globally, AFib cases nearly doubled in under a decade, rising from 33.5 million in 2010 to roughly 60 million by 2019. Now, scientific curiosity is mounting in how gum disease might be contributing to that surge.
Researchers have discovered DNA from harmful oral bacteria in heart muscle, valves, and even fatty arterial plaques.
Among them, P. gingivalis has drawn particular scrutiny for its suspected role in a growing list of systemic diseases, including Alzheimer's, diabetes, and certain cancers.
It has previously been detected in the brain, liver, and placenta. But how it manages to take hold in the heart has been unclear.
This study, published in Circulation, provides the first clear evidence that P. gingivalis in the gums can worm its way into the left atrium in both animal models and humans, pointing to a potential microbial pathway linking periodontitis to AFib.
"The causal relationship between periodontitis and atrial fibrillation is still unknown, but the spread of periodontal bacteria through the bloodstream may connect these conditions," said study first author Shunsuke Miyauchi, assistant professor at HU's Graduate School of Biomedical and Health Sciences.
"Among various periodontal bacteria, P. gingivalis is highly pathogenic to periodontitis and some systemic diseases outside the oral cavity. In this study, we have addressed these two key questions: Does P. gingivalis translocate to the left atrium from the periodontitis lesion? And if so, does it induce the progression of atrial fibrosis and AFib?" added Miyauchi.
To simulate how P. gingivalis might escape the mouth and create problems elsewhere, researchers created a mouse model using the bacterium's aggressive W83 strain.
They divided 13-week-old male mice into two groups: one had the strain introduced into the tooth pulp, the other remained uninfected.
Each was further split into subgroups and observed for either 12 or 18 weeks to track the cardiovascular risks of prolonged exposure.
Intracardiac stimulation -- a diagnostic technique for arrhythmia -- revealed no difference in AFib risk between infected and uninfected mice at 12 weeks.
But by week 18, tests showed that mice exposed to the bacterium were six times more likely to develop abnormal heart rhythms, with a 30% AFib inducibility rate compared to just 5% in the control group.
To see if their model accurately replicated periodontitis, the researchers examined jaw lesions and found its telltale signs.
They detected tooth pulp decay and microabscesses caused by P. gingivalis. But the damage did not stop there. They also spotted the bacterium in the heart's left atrium, where infected tissue had turned stiff and fibrous.
Using loop-mediated isothermal amplification to detect specific genetic signatures, the team confirmed that the P. gingivalis strain they had introduced was present in the heart.
In contrast, the uninfected mice had healthy teeth and no trace of the bacterium in heart tissue samples.
Twelve weeks after infection, mice exposed to P. gingivalis already showed more heart scarring than their uninfected counterparts.
At 18 weeks, scarring in the infected mice had climbed to 21.9% compared to the likely ageing-related 16.3% in the control group, suggesting that P. gingivalis may not just trigger early heart damage, but also speed it up over time.
And this troubling connection was not only seen in mice. In a separate human study, researchers analysed left atrial tissue from 68 AFib patients who underwent heart surgery. P. gingivalis was found there, too, and in greater amounts in people with severe gum disease. (ANI)
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Hindu
8 hours ago
- The Hindu
Pseudodementia: when depression masquerades as dementia
Memory loss is often associated with conditions such as Alzheimer's disease or other irreversible dementias. However, a frequently overlooked but potentially reversible condition --pseudodementia -- can cause similar cognitive deficits. Pseudodementia occurs when depression or other mental health disorders lead to significant impairments in memory, concentration and other cognitive functions that closely resemble dementia. Understanding pseudodementia Pseudodementia is most frequently associated with major depressive disorder. Typically, it presents as cognitive dysfunction, such as forgetfulness, inability to focus, slowing of thought processing, and indecision. Whereas degenerative dementias are usually characterised by a global and profound inability to understand one's cognitive decline, and patients suffering from pseudodementia often have an acute awareness of their cognitive deficits and can show in their demeanour a certain degree of frustration, or even get upset, specifically related to their inability to think. Pseudodementia can arise from several life situations, such as life stressors, chronic illness, or social isolation and can affect adults and in rare cases, younger individuals. Pseudodementia versus dementia Although some symptoms may be similar to dementia, several identifying features help differentiate pseudodementia. The onset and progression are usually observable over a period of weeks to months, whereas dementia develops slowly over years. Patients with pseudodementia are often aware of their symptoms and can be bothered by them, while people with dementia may not demonstrate such awareness. Cognitive evaluation may also differ -- individuals with pseudodementia may show variability in performance or give up on difficult tasks sooner than dementia patients, who continue to struggle despite effort. Importantly, once the underlying depression is treated, cognitive abilities can often improve significantly, a feature not seen in neurodegenerative dementias. Evaluation and diagnosis Getting an accurate diagnosis is critical because pseudodementia is treatable. The diagnostic process typically involves obtaining a comprehensive history from both the patient and an informant, often a family member, to establish the time course of symptom onset. Cognitive assessments such as the Mini-Mental State Examination (MMSE) and the Montreal Cognitive Assessment (MoCA), along with depression screening tools like the Geriatric Depression Scale, are used. Medical tests are conducted to exclude other reversible conditions that mimic dementia, such as thyroid disease, vitamin B12 deficiency, and anaemia. Brain imaging may also be performed to rule out structural causes of cognitive changes. In some cases, a thorough neuropsychological evaluation is warranted to determine the extent and pattern of cognitive impairment. Studies have shown that cognitive impairment associated with depression is pervasive but can be effectively treated. This highlights the need for education, both in the public and healthcare systems, for proper identification and treatment. Management, prognosis and the path to recovery Management strategy primarily addresses the depression itself, which typically consists of antidepressant drugs, psychotherapy and several lifestyle strategies in the treatment of depression such as exercise, socialisation and good sleep hygiene. Usually, improvement in mood will correlate with improvement in cognition. However, in this case, time is of the essence. Untreated major depression, can not only prolong cognitive symptoms, but may put the person at risk for later true dementia. Memory loss is not an inevitable part of ageing, and many conditions like pseudodementia are reversible with proper care. Early identification and treatment of depression are crucial to prevent long-term cognitive decline. Families should seek a full clinical assessment whenever rapid cognitive changes or mood symptoms appear in a loved one. Recovery often involves a combination of medical treatment, mental health support and healthy lifestyle changes, including regular exercise, good sleep, social engagement and proper nutrition. With timely intervention, cognitive function can improve significantly, offering patients and their families a tangible path to better brain health. (Dr. Keni Ravish Rajiv is senior consultant, Neurology and Head of Epilepsy Services, Aster Whitefield Hospital, Bengaluru.
Time of India
a day ago
- Time of India
Eating almond with skin causes inflammation? Here's what a doctor says
Almonds have been a kitchen staple for centuries, a trusted source of nourishment, flavor, and tradition. But if you're eating them raw, straight from the bag, you might be getting more than just healthy fats and protein. You're also consuming lectins, plant-based proteins found in the skins of almonds and many other foods. Lectins evolved in plants as a defense mechanism to deter pests. In some cases, they can cause digestive discomfort or inflammation in sensitive individuals. But how worried should the average almond lover be? Let's dig in. The benefits of almonds Almonds are nutritional powerhouses. They're rich in fiber and healthy fats that promote digestion, support heart health, and help you stay fuller for longer. They're also an excellent source of vitamin E and antioxidants, which protect brain cells from oxidative stress. Soaking almonds is a long-standing tradition in many cultures. It softens their texture, makes them slightly sweeter, and may improve digestibility. However, scientific evidence for significantly better nutrient absorption from soaking is limited. The lectin question Dr. Robert Love, a neuroscientist specializing in Alzheimer's prevention, told his followers: 'Eating raw almonds with their skins may expose you to lectins, potentially causing inflammation.' by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Learn More - How Donating Sperm May Boost Your Income SpellRock Undo He recommends soaking, peeling, and lightly roasting almonds to get the best of both flavor and brain health benefits. But here's the key context: almond skins do contain lectins, but the levels are far lower than those in 'problem foods' like raw kidney beans, which have high amounts of phytohaemagglutinin that can cause nausea, vomiting, and diarrhea if undercooked. In healthy adults, the amount of lectin in almonds is unlikely to cause harm unless eaten in unusually large quantities or if you have a specific sensitivity. What the science says Harvard nutrition experts note that lectin-rich foods, including legumes, grains, and nuts, are consistently linked to lower rates of chronic diseases, not higher. Cooking, soaking, or roasting can reduce lectin content, but for most people, raw almond skins are not a dangerous source. Capay Hills Orchard adds that almond skins are packed with antioxidants and fiber. Removing them might reduce these benefits unless you have a diagnosed digestive sensitivity or an autoimmune condition that worsens with lectin-rich foods. Should you soak and peel? For most people, eating raw almonds, skins and all, is safe and beneficial. If you have digestive discomfort after eating them, soaking and peeling may help. Roasting can also reduce lectin activity and enhance flavor. But if you have no issues, there's no strong evidence that you need to avoid almond skins.
India.com
a day ago
- India.com
Women with Down Syndrome Show Faster Alzheimer's Progression Than Men, Study Finds
New Delhi: Women with Down syndrome have more advanced signs of Alzheimer's disease than men do, according to research. However, the average age of Down syndrome diagnosis is the same for both men and women, said the University of California, Irvine. The study suggests that women with Down syndrome may carry a higher burden of beta amyloid and phosphorylated tau -- two hallmark Alzheimer's proteins -- than men. It was particularly high in the occipital lobe in women with sporadic Alzheimer's disease -- the more common, late-onset form of Alzheimer's that occurs without a clear genetic cause. This insight points to the need for more sex-specific approaches in both Alzheimer's research and treatment planning, especially in the design of clinical trials. Women versus men "Understanding selective vulnerabilities within the brain and how these differ in women versus men will help us to better navigate treatment outcomes. We're learning the importance of modifiable risk factors, which include accounting for sex-specific risk," said lead author Elizabeth Andrews, doctoral candidate at the varsity. Alzheimer's disease is the primary cause of death for individuals with Down syndrome, who are genetically predisposed to develop the condition earlier in life. While previous studies observed that women with Down syndrome may live longer with dementia than men with Down syndrome, few have looked closely at whether the underlying brain pathology differs by sex. Researchers examined postmortem brain samples In this study, the researchers examined postmortem brain samples and measured levels of beta amyloid and tau. The findings, published in the journal Alzheimer's & Dementia, can shape how we understand and approach treatments for Alzheimer's in this population and beyond. "If women with Down syndrome are further along in disease progression at the time of diagnosis, it could change how we time interventions and interpret outcomes in clinical trials," said Elizabeth Head, Professor of pathology at UC Irvine. "This research could help tailor therapies more effectively, not just for people with Down syndrome, but for the broader Alzheimer's population as well," Head added.
